RecruitingPhase 4NCT06543550

Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis

Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis: Randomized Controlled Clinical Trial


Sponsor

Bio Meds Pharmaceutica Ltda

Enrollment

70 participants

Start Date

Jul 30, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the effects of therapy with implantable Gestrinone compared to oral Dienogest in relieving complaints related to endometriosis.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria2

  • Adult female patients of menstrual age, pre-menopause (18 to 45 years old), who seek medical treatment to alleviate complaints related to endometriosis, who are not undergoing other therapies to treat them.
  • Patients must have a diagnosis of Grade 1 or 2 endometriosis assessed by imaging tests (ultrasound with bowel preparation and/or MRI of the pelvis with bowel preparation)14, have a BMI of up to 25kg/m2, and weigh between 50 and 70kg.

Exclusion Criteria5

  • Pregnant patients (supporting test must be presented)
  • Breastfeeding women, using other hormonal contraceptive methods or copper or silver IUDs, who have polycystic ovaries, and/or hyperandrogenism.
  • Patients using medications that may interfere with androgen metabolism within 4 weeks of screening or during the study.
  • Patients with a history of liver disease, cardiovascular disease (myocardial infarction, unstable angina or heart failure), active hepatitis, liver neoplasia or renal failure
  • Patient who are scheduled for surgical treatment during the study period.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGImplantable gestrinone

1.6mg/kg of weight of gestrinone in pellets (bio meds Brasil, Florianópolis, Brazil) subcutaneously, in the gluteal region.

DRUGOral Dienogest

Administered orally at 2 mg daily


Locations(4)

Gm Ignacio Atividade Medica LTDA

Brasília, Federal District, Brazil

Instituto Longevite Servicos Medicos LTDA

Campina Grande, Paraíba, Brazil

Jpml Clinica Medica LTDA

São José dos Campos, São Paulo, Brazil

Dra Juliana Bicca Endocrinologia e Medicina Funcional LTDA

São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06543550


Related Trials